Physician

Asim Amin, MD

According to 2025 Medicare claims, Asim Amin, MD (NPI: 1518965607) practices medical oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1508135799; TIN: 56-0529945) and primary practice location at 28204-2990. Amin is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Amin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 194 traditional Medicare patients, billed 697 HCPCS/CPT codes, and received $63,979 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 693 prescription claims across 106 beneficiaries totaling $3,869,122 in drug costs, led by Lenvima (Lenvatinib Mesylate). 2023 DME data shows 73 claims. Open Payments data shows 12 records totaling $783,546. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $53,351 to $63,979. Similarly, Part D prescription costs have risen steadily, from $635,788 to $3,869,122. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	192	1,079	$53,351
2016	192	1,113	$54,813
2017	172	696	$43,123
2018	181	671	$40,806
2019	212	924	$56,460
2020	194	881	$53,086
2021	197	869	$69,274
2022	195	797	$76,620
2023	192	778	$75,163
2024	194	697	$63,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	85	413	$635,788
2016	84	394	$1,043,508
2017	75	408	$1,793,013
2018	95	586	$2,982,660
2019	109	760	$3,696,777
2020	81	542	$3,478,417
2021	75	575	$4,238,828
2022	77	567	$3,055,184
2023	100	612	$3,023,513
2024	106	693	$3,869,122

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	37	$4,397
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	73	$1,775
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	37	37	$131
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	156	460	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	76	180	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenvima	Lenvatinib Mesylate	79	2,370	$1,873,611
Braftovi	Encorafenib	43	1,290	$666,658
Mektovi	Binimetinib	43	1,290	$510,538
Welireg	Belzutifan	17	510	$458,921
Everolimus	Everolimus	29	812	$104,101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$4,035	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$779,511	Atrium Health Union
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asim Amin, MD?

Tedicare shows public-source Medicare data for Asim Amin, MD (NPI 1518965607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asim Amin, MD have ACO affiliation data?

Asim Amin, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Asim Amin, MD?

Asim Amin, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1508135799) in the available physician profile data.

Does Asim Amin, MD have Open Payments data?

Asim Amin, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.